A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

The firm will make its artificial intelligence-based Lunit SCOPE IO platform available to SITC member researchers.

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

The Cancer Vaccines Market is witnessing significant expansion, driven by rising cancer prevalence and advancements in ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

This year’s World Cancer Day theme, ‘United by Unique,’ emphasizes a people-centred approach to cancer care, encouraging us ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...

Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...

A new artificial intelligence model developed by Stanford Medicine combines clinical notes and pathology images to predict ...

The first phase of the new Cancer Center at Valley Medical Center in Renton opened to patients on Monday, launching the ...

Immunotherapy has shown a 27% reduction in mortality for patients with limited-stage small cell lung cancer, based on Phase ...